Partnering opportunities

Diabetes companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop diabetes technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search
Refine

19 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ data.total | number }]} opportunities

19 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ row.country }]}

Development of a novel type of tolerogenic vaccine : a negative self-vaccine against type 1 diabetes.

T1D is an autoimmune form of diabetes mellitus in which not enough insulin is produced. T1D makes up an estimated 5–10% of all diabetes cases. The number of people affected globally... more

Belgium

A French Technology Transfer Office offers a new compound for the treatment of diabetes

insulin and glucose metabolism. These kinds of intolerance cause serious damage such as liver fibrosis and abnormal fat liver content. Diabetes represents high levels of blood sugar over a long period. Therapies... more

France

[EUREKA/Eurostars2]New drugs applicable on cancer, obese, diabetes, Alzheimer, brain disease, inflammation, and metabolic disease

A Korean SME has established in 2017 and focused on the development of treatment for the terminal and chronic disease. Novel promising pipelines (Anti-neoplastic drugs, Arthritis, Diabetes, Obesity, Alzheimer,... more

South Korea

Photoplethysmography technology for non-invasive blood glucose detection and monitoring

According to the 2017 statistics by the International Diabetes Federation, globally, there are 425 million people living with diabetes and by 2045 and the number of diabetics is projected... more

Singapore

Novel drugs for the treatment of chronic wounds

Diabetes mellitus is one of the major health concerns worldwide affecting 425 million people and its prevalence is expected to increase to 629 million by 2045. It is estimated that 12% of the global health expenditure... more

Switzerland

UK-based SME offers implantable sensor for glucose measuring and monitoring

Diabetes is a chronic health condition that is affecting increasing numbers of people globally and can have serious impacts for patients in the longer term. It is a condition that requires careful and consistent... more

United Kingdom

UK SME offers sensor for finger-prick glucose monitoring devices

Diabetes is a health condition that is causing a great deal of concern both due to the long-term impacts of the condition on patients and due to the increase in number of people affected. It is a condition that... more

United Kingdom

A Finnish company is looking for licensees for a mobile health platform

a mobile terminal either manually or by automatic wireless data transfers from measuring devices like blood pressure and glucose meters. The service is developed for patients with chronic diseases like diabetes,... more

Finland

French Technology Transfer Office proposes a patented collagen-based hydrogel for wound care products

drawbacks of this technique are : -the frequent changes of dressings -the numerous types of materials required (according to the stage of healing) -The costs of hospital/nurse The population is aging in western countries and diabetes... more

France

Pharmaceutical compositions that act as adenosine receptor antagonist which cures liver diseases, such as Nonalcoholic steatohepatitis (NASH), liver fibrosis, cirrhosis of liver containing adenosine derivatives

A Korean company established in 2015 is based on research of pharmaceutical products and drugs. Nonalcoholic fatty liver disease (NAFLD) is caused by obesity and diabetes, and it includes simple steatosis, Nonalcoholic... more

South Korea

Click-mass spectrometry of lipids.

understand and detect diseases, such as, metabolic syndrome or type 2 diabetes. For studying the lipid metabolism, it is common that labeled precursor substances are administered to a test system, in which they... more

Germany

Click-mass spectrometry of lipids.

understand and detect diseases, such as, metabolic syndrome or type 2 diabetes. For studying the lipid metabolism, it is common that labeled precursor substances are administered to a test system, in which they... more

Germany

A French pharmaceutical company is looking for projects targeting the resolution of inflammation phase in autoimmune or chronic immuno-inflammatory diseases

research centers and 16 production sites this French company has a global reach. With 33 drug candidates in clinical development, they are specialized in 5 major axes: cardiovascular diseases, diabetes, cancers,... more

France

Technical product development for medical devices

core temperature by venous perfusion to approximately 42,5°C for two hours in support of an oncological treatment. - Hyperthermic intraperitoneal chemotherapy anesthesia - Hemodialyse with molecular biology - Diabetes... more

Netherlands

Method for measuring lipoprotein lipase activity in human plasma for drug development and hypertriglyceridemia research

Recent studies suggest that hypertriglyceridemia (elevated levels of plasma triglycerides) is an independent risk factor for atherosclerosis. Hypertriglyceridemia has been identified as an early event in the development of type 2 diabetes more

Estonia

Technical product development for medical devices

core temperature by venous perfusion to approximately 42,5°C for two hours in support of an oncological treatment. - Hyperthermic intraperitoneal chemotherapy anesthesia - Hemodialyse with molecular biology - Diabetes... more

Netherlands

Portable medical device to address metabolic and related chronic diseases and assist with clinical weight loss

Obesity is a global problem and is a known risk factor for many chronic diseases, including heart disease, type 2 diabetes and some cancers. Relatively small reductions in weight (5-10%) can lead to significant... more

United Kingdom

Artificial Intelligence (AI) in the service of investigating the correlations and the enhanced treating of the multiple chronic diseases

conditions. The constantly ageing population will only increase the magnitude of this challenge. Chronic conditions require ongoing medical attention and/or limit activities of daily living. Examples include arthritis, diabetes,... more

Greece

Personal Decision Support System as a Mobile Application for Heart Failure Management

example, the exercise programme depends on the patient’s physical capacity and current heart rate, while the nutrition education is adapted to the patient’s comorbidities (diabetes etc.) and focuses on topics... more

Slovenia

The right partner not here?

Get in touch and we'll help you post a partnering opportunity

Hash